BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6458503)

  • 21. Hemodynamic effects of a new histamine H2 receptor agonist (impromidine) and antagonist (ranitidine).
    Pollock DM; Banks RO; Jacobson ED
    Pharmacol Res Commun; 1982 Jul; 14(7):605-12. PubMed ID: 6127724
    [No Abstract]   [Full Text] [Related]  

  • 22. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
    Seifert R; Höer A; Schwaner I; Buschauer A
    Mol Pharmacol; 1992 Aug; 42(2):235-41. PubMed ID: 1381044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of histamine H1-, H2- and H3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine.
    Leurs R; Brozius MM; Smit MJ; Bast A; Timmerman H
    Br J Pharmacol; 1991 Jan; 102(1):179-85. PubMed ID: 1646056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine H2 receptor antagonists may modify dog intestinal motility independently of their primary action on the H2 receptors.
    Bertaccini G; Coruzzi G; Poli E
    Pharmacol Res Commun; 1985 Mar; 17(3):241-54. PubMed ID: 2861607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
    Elz S; Schunack W
    Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intracerebroventricular impromidine on pituitary-adrenocortical response to stress in rats.
    Bugajski J; Gadek A
    Agents Actions; 1984 Jun; 14(5-6):569-73. PubMed ID: 6236678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of IgE-mediated histamine release from human leukocytes by a new class of histamine H2-agonists.
    Kleine-Tebbe J; Buschauer A; Friese A; Schunack W; Kunkel G
    Agents Actions; 1992 Mar; 35(3-4):185-91. PubMed ID: 1382368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the agonist activity of impromidine (SK & F 92676) in anaesthetized rabbits and on the rabbit isolated fundic mucosa.
    Curwain BP; Turner NC
    Br J Pharmacol; 1981 Aug; 73(4):917-9. PubMed ID: 6456031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impromidine, a potent inhibitor of histamine methyltransferase (HMT) and diamine oxidase (DAO).
    Beaven MA; Roderick NB
    Biochem Pharmacol; 1980 Oct; 29(20):2897-900. PubMed ID: 6449204
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct and indirect actions of impromidine (a new H2-receptor agonist) on atrial tissue.
    Hughes MJ
    Life Sci; 1981 Aug; 29(8):817-24. PubMed ID: 6170857
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of histamine and prostaglandin D2 on rat mast-cell cyclic AMP and mediator release.
    Wescott S; Kaliner M
    J Allergy Clin Immunol; 1981 Nov; 68(5):383-91. PubMed ID: 6271862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of impromidine, a specific H2-receptor agonist and 2(2-pyridyl)-ethylamine, an H1-receptor agonist, on stimulation-induced release of [3H]-noradrenaline in guinea-pig isolated atria.
    Rand MJ; Story DF; Wong-Dusting H
    Br J Pharmacol; 1982 Jun; 76(2):305-11. PubMed ID: 6212093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impromidine, a potent dilator of cat pial arterioles.
    Gross PM; Harper AM; Teasdale GM
    Eur J Pharmacol; 1981 Jul; 73(2-3):225-7. PubMed ID: 6458501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some central effects of impromidine, a potent agonist of histamine H2 receptors.
    Pilc A; Rogóz Z; Byrska B
    Neuropharmacology; 1980 Oct; 19(10):947-50. PubMed ID: 6158709
    [No Abstract]   [Full Text] [Related]  

  • 35. Impromidine-induced hypothermia in rats: effect of cimetidine and mianserine.
    Nowak JZ
    Agents Actions; 1982 Apr; 12(1-2):148-52. PubMed ID: 6282072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro anti-tumour activity of dimaprit.
    Fray A; Burtin C; Scheinmann P; Lespinats G; Canu P
    Agents Actions; 1985 Apr; 16(3-4):284-6. PubMed ID: 3160225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists.
    Badger AM; Young J; Poste G
    Clin Exp Immunol; 1983 Jan; 51(1):178-84. PubMed ID: 6219840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipemic responses induced by centrally administered histamine H1- and H2-receptor agonists in rats.
    Bugajski J; Gadek A
    Agents Actions; 1987 Apr; 20(3-4):255-7. PubMed ID: 2955677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
    Vinik AI; Heldsinger AA; Skoglund ML
    J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations.
    Dam Trung Tuong M; Garbarg M; Schwartz JC
    Nature; 1980 Oct; 287(5782):548-51. PubMed ID: 6106900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.